Charles River Laboratories | CRL - 员工 总数



金融业
股票价格
USD
资产
USD 7.53B
现金及等价物
USD 192.03M
销售成本
USD 655.29M
流动资产
USD 1.53B
流动负债
USD 1.13B
债务
USD 3.06B
EBIT
USD 119.89M
EBITDA
USD 272.95M
员工
18.6K
EPS每股收益
USD 3.02
股本和储备
USD 2.84B
销售毛利
USD 348.79M
债务利息支出
USD 30.34M
利息收入
USD -0.03
贷款资金
USD 2.62B
市值
USD 14.86B
净收入
USD -1.48M
营业费用
USD 2.84B
营业利润
USD 119.89M
普通股股本
USD 47.73M
PE价格收益
58.27
税前利润
USD -29.94M
销售收入
USD 1B
销售和管理费用
USD 228.9M
股票
USD 346.26M
贸易债权人
USD 140.98M
应收帐款人
USD 711.76M


员工 更改 日
Agilent 17.9K 200 2024-10
Align Technology 20.94K 665 2024-12
Bio-Rad Laboratories 8.03K 170 2023-12
Bruker 9.71K 1.18K 2023-12
Cardinal Health 57.7K 8.8K 2025-12
Charles River Laboratories 18.6K 1.4K 2024-12
Cigna 73.5K 1000 2024-12
Concord Medical Services Hldg CNY 918 54 2022-12
CVS Health 300K 0 2024-12
Danaher 61K 18K 2023-12
Dentsply International 14K 1000 2024-12
Elevance Health 104.9K 2.6K 2023-12
Humana 65.68K 1.92K 2024-12
Illumina 8.97K 1.62K 2024-12
Incyte 2.62K 93 2024-12
Intrexon 202 7 2023-12
IQVIA Holdings 88K 1000 2024-12
Laboratory Of America 70K 3K 2024-12
Lakefront Biotherapeutics 1.34K 29 2022-12
Lonza 17.49K 1.28K 2022-12
McKesson 45K 13K 2023-03
Merck 64.23K 3.9K 2022-12
Mettler Toledo International 16K 400 2023-12
Novartis USD 101.7K 2.62K 2022-12
Pfizer 81K 7K 2024-12
Quest Diagnostics 40K 0 2023-12
Revvity 11K 500 2024-12
Thermo Fisher Scientific 125K 3K 2024-12
United Therapeutics 1.3K 137 2024-12
UnitedHealth 400K 40K 2024-12
Veradigm 8K 400 2021-12
Waters 7.6K 300 2024-12
West Pharmaceutical Services 10.6K 0 2024-12